stockrowMBX Biosciences, Inc. (MBX) vs Septerna, Inc. (SEPN)
- MBX Biosciences, Inc. MBX 51.27 +5.80%
- Septerna, Inc. SEPN 48.95 +3.38%
MBX Biosciences, Inc. and Septerna, Inc. are both Biotechnology companies. MBX Biosciences, Inc. and Septerna, Inc. are of similar size ($2.3B and $2.2B). MBX Biosciences, Inc. has the higher net margin (0.00% vs −24.5%) and the higher return on invested capital (0.00% vs −189.0%). Across the 12 metrics below, Septerna, Inc. leads on 7 and MBX Biosciences, Inc. on 5.
Valuation
Profitability
| Metric | MBX | SEPN | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 68.51% |
| Operating margin | 0.00% | (44.04%) | 0.00% |
| Net margin | 0.00% | (24.51%) | 0.00% |
| Free cash flow margin | 0.00% | 118.93% | 0.00% |
| Return on equity | (33.17%) | (6.34%) | (51.96%) |
| Return on assets | (31.25%) | (4.94%) | (46.06%) |
| Return on invested capital | 0.00% | (189.01%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack